Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/11958
Título: | Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment |
Autor(es): | Brekke, Kurt R. Holmås, Tor Helge Straume, Odd Rune |
Palavras-chave: | Pharmaceuticals Regulation Generic competition |
Data: | Mar-2011 |
Editora: | Elsevier 1 |
Revista: | Journal of Public Economics |
Citação: | "Journal of Public Economics". ISSN 0047-2727. |
Resumo(s): | We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on prices and market shares of brand-names and generics. Then, we exploit a detailed panel data set at product level covering several off-patent molecules before and after the policy reform. Off-patent drugs not subject to RP serve as our control group. We find that RP significantly reduces both brand-name and generic prices, and results in significantly lower brand-name market shares. Finally, we show that RP has a strong negative effect on average molecule prices, suggesting significant cost-savings, and that patients’ copayments decrease despite the extra surcharges under RP. |
Tipo: | Artigo |
URI: | https://hdl.handle.net/1822/11958 |
DOI: | 10.1016/j.jpubeco.2010.11.015 |
ISSN: | 0047-2727 |
Arbitragem científica: | yes |
Acesso: | Acesso aberto |
Aparece nas coleções: | NIPE - Artigos em Revistas de Circulação Internacional com Arbitragem Científica |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
RP_merged.pdf | Reference pricing, competition, and pharmaceutical expenditures | 292,03 kB | Adobe PDF | Ver/Abrir |